Press "Enter" to skip to content

New patent for Astrazeneca Ab drug BYDUREON PEN

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug BYDUREON PEN

Annual Drug Patent Expirations for BYDUREON+PEN
Annual Drug Patent Expirations for BYDUREON+PEN

Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two patents protecting this drug.

The generic ingredient in BYDUREON PEN is exenatide synthetic. One supplier is listed for this compound. Additional details are available on the exenatide synthetic profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug BYDUREON PEN
DrugPatentWatch - Make Better Decisions